Development of MRF for Characterization of Brain Tumors After Radiotherapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Lan Lu, PhD
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Principal Investigator - Samuel Chao, MD
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Lan Lu, PhDSamuel Chao, MDRecruiting - University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Oct 2024
- Primary completion
- 31 Jan 2027
- Completion
- 30 Sept 2027
- Last update posted
- 20 Oct 2026
- Registered enrollment
- 90
- Registry id
- NCT06101069
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.